Skip to main content
Top
Published in: Drugs 12/2010

01-08-2010 | Therapy in Practice

Laxative Abuse

Epidemiology, Diagnosis and Management

Authors: James L. Roerig, Kristine J. Steffen, Professor James E. Mitchell, Christie Zunker

Published in: Drugs | Issue 12/2010

Login to get access

Abstract

Laxatives have been used for health purposes for over 2000 years, and for much of that time abuse or misuse of laxatives has occurred. Individuals who abuse laxatives can generally be categorized as falling into one of four groups. By far the largest group is made up of individuals suffering from an eating disorder such as anorexia or bulimia nervosa. The prevalence of laxative abuse has been reported to range from approximately 10% to 60% of individuals in this group. The second group consists of individuals who are generally middle aged or older who begin using laxatives when constipated but continue to overuse them. This pattern may be promulgated on certain beliefs that daily bowel movements are necessary for good health. The third group includes individuals engaged in certain types of athletic training, including sports with set weight limits. The fourth group contains surreptitious laxative abusers who use the drugs to cause factitious diarrhoea and may have a factitious disorder.
Normal bowel function consists of the absorption of nutrients, electrolytes and water from the gut. Most nutrients are absorbed in the small intestine, while the large bowel absorbs primarily water. There are several types of laxatives available, including stimulant agents, saline and osmotic products, bulking agents and surfactants. The most frequently abused group of laxatives are of the stimulant class. This may be related to the quick action of stimulants, particularly in individuals with eating disorders as they may erroneously believe that they can avoid the absorption of calories via the resulting diarrhoea.
Medical problems associated with laxative abuse include electrolyte and acid/base changes that can involve the renal and cardiovascular systems and may become life threatening. The renin-aldosterone system becomes activated due to the loss of fluid, which leads to oedema and acute weight gain when the laxative is discontinued. This can result in reinforcing further laxative abuse when a patient feels bloated and has gained weight.
Treatment begins with a high level of suspicion, particularly when a patient presents with alternating diarrhoea and constipation as well as other gastrointestinal complaints. Checking serum electrolytes and the acid/base status can identify individuals who may need medical stabilization and confirm the severity of the abuse. The first step in treating laxative misuse once it is identified is to determine what may be promoting the behaviour, such as an eating disorder or use based on misinformation regarding what constitutes a healthy bowel habit. The first intervention would be to stop the stimulant laxatives and replace them with fibre/osmotic supplements utilized to establish normal bowel movements. Education and further treatment may be required to maintain a healthy bowel programme. In the case of an eating disorder, referral for psychiatric treatment is essential to lessen the reliance on laxatives as a method to alter weight and shape.
Literature
1.
go back to reference Phelps L, Andrea R, Rizzo FG, et al. Prevalence of self-induced vomiting and laxative/medication abuse among female adolescents: a longitudinal study. Int J Eat Disord 1993; 14: 375–8PubMedCrossRef Phelps L, Andrea R, Rizzo FG, et al. Prevalence of self-induced vomiting and laxative/medication abuse among female adolescents: a longitudinal study. Int J Eat Disord 1993; 14: 375–8PubMedCrossRef
2.
go back to reference Tozzi F, Thornton LM, Mitchell JE, et al., on behalf of the Price Foundation Collaborative Group. Features associated with laxative abuse in individuals with eating disorders. Psychosom Med 2006; 68: 470–7PubMedCrossRef Tozzi F, Thornton LM, Mitchell JE, et al., on behalf of the Price Foundation Collaborative Group. Features associated with laxative abuse in individuals with eating disorders. Psychosom Med 2006; 68: 470–7PubMedCrossRef
4.
go back to reference Wills S. Drugs and substance misuse: over-the-counter products. Pharm J 1993; 251: 807–10 Wills S. Drugs and substance misuse: over-the-counter products. Pharm J 1993; 251: 807–10
5.
go back to reference Marquart LF, Sobal J. Weight loss beliefs, practices and support systems for high school wrestlers. J Adolesc Health 1994; 15: 410–5PubMedCrossRef Marquart LF, Sobal J. Weight loss beliefs, practices and support systems for high school wrestlers. J Adolesc Health 1994; 15: 410–5PubMedCrossRef
6.
go back to reference Shelton JH, Santa Ana CA, Thompson DR, et al. Factitious diarrhea induced by stimulant laxatives: accuracy of diagnosis by a clinical reference laboratory using thin layer chromatography. Clin Chem 2007; 53: 85–90PubMedCrossRef Shelton JH, Santa Ana CA, Thompson DR, et al. Factitious diarrhea induced by stimulant laxatives: accuracy of diagnosis by a clinical reference laboratory using thin layer chromatography. Clin Chem 2007; 53: 85–90PubMedCrossRef
7.
go back to reference Keswani RJ, Sauk J, Kane SV. Factitious diarrhea masquerading as refractory celiac disease. South Med J 2006; 99: 293–5PubMedCrossRef Keswani RJ, Sauk J, Kane SV. Factitious diarrhea masquerading as refractory celiac disease. South Med J 2006; 99: 293–5PubMedCrossRef
8.
go back to reference Vanin JR, Saylor KE. Laxative abuse: a hazardous habit for weight control. J Am Coll Health 1989; 37: 227–30PubMedCrossRef Vanin JR, Saylor KE. Laxative abuse: a hazardous habit for weight control. J Am Coll Health 1989; 37: 227–30PubMedCrossRef
9.
go back to reference Pomeroy C, Mitchell JE, Roerig J, et al. Medical complications of psychiatric illness. Washington, DC: American Psychiatric Publishing, Inc., 2002 Pomeroy C, Mitchell JE, Roerig J, et al. Medical complications of psychiatric illness. Washington, DC: American Psychiatric Publishing, Inc., 2002
11.
go back to reference Furness JB, Sanger GJ. Intrinsic nerve circuits of the gastrointestinal tract: identification of drug targets. Curr Opinion Pharmacol 2002; 2: 612–22CrossRef Furness JB, Sanger GJ. Intrinsic nerve circuits of the gastrointestinal tract: identification of drug targets. Curr Opinion Pharmacol 2002; 2: 612–22CrossRef
12.
go back to reference Galligan J. Pharmacology of synaptic transmission in the enteric nervous system. Curr Opin Pharmacol 2002; 2: 623–9PubMedCrossRef Galligan J. Pharmacology of synaptic transmission in the enteric nervous system. Curr Opin Pharmacol 2002; 2: 623–9PubMedCrossRef
13.
go back to reference Hansen MB. The enteric nervous system I: organization and classification. Pharmacol Toxicol 2003; 92: 105–13PubMedCrossRef Hansen MB. The enteric nervous system I: organization and classification. Pharmacol Toxicol 2003; 92: 105–13PubMedCrossRef
14.
go back to reference Camilleri M, Murray JA. Chapter 40: diarrhea and constipation. In: Fauci AS, Braunwald E, Kasper DL, et al., editors. Harrison’s principles of internal medicine. 17th ed. New York: The McGraw-Hill Companies, 2008: 245–54 Camilleri M, Murray JA. Chapter 40: diarrhea and constipation. In: Fauci AS, Braunwald E, Kasper DL, et al., editors. Harrison’s principles of internal medicine. 17th ed. New York: The McGraw-Hill Companies, 2008: 245–54
15.
go back to reference Pasricha PJ. Chapter 37: treatment of disorders of bowel motility and water flux; antiemetics; agents used in biliary and pancreatic disease. In: Brunton L, Lazo J, Parker K, editors. Goodman & Gilman’s the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill Professional, 2006: 983–1008 Pasricha PJ. Chapter 37: treatment of disorders of bowel motility and water flux; antiemetics; agents used in biliary and pancreatic disease. In: Brunton L, Lazo J, Parker K, editors. Goodman & Gilman’s the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill Professional, 2006: 983–1008
16.
go back to reference Tonini M, Cipollina L, Poluzzi E, et al. Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther 2004; 19: 379–90PubMedCrossRef Tonini M, Cipollina L, Poluzzi E, et al. Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther 2004; 19: 379–90PubMedCrossRef
18.
go back to reference Nguyen NQ, Chapman M, Fraser RJ, et al. Prokinetic therapy for feed intolerance in critical illness: one drug or two? Crit Care Med 2007; 35: 2561–7PubMedCrossRef Nguyen NQ, Chapman M, Fraser RJ, et al. Prokinetic therapy for feed intolerance in critical illness: one drug or two? Crit Care Med 2007; 35: 2561–7PubMedCrossRef
19.
go back to reference Neims DM, McNeill J, Giles TR, et al. Incidence of laxative abuse in community and bulimic populations: a descriptive review. Int J Eat Disord 1995; 17: 211–28PubMedCrossRef Neims DM, McNeill J, Giles TR, et al. Incidence of laxative abuse in community and bulimic populations: a descriptive review. Int J Eat Disord 1995; 17: 211–28PubMedCrossRef
20.
go back to reference Abraham SF, Beumont PJ. How patients describe bulimia or binge eating. Psychol Med 1982; 12: 625–35PubMedCrossRef Abraham SF, Beumont PJ. How patients describe bulimia or binge eating. Psychol Med 1982; 12: 625–35PubMedCrossRef
21.
go back to reference Cooper PJ, Fairburn CG. Cognitive behaviour therapy for anorexia nervosa: some preliminary findings. J Psychosom Res 1984; 28: 493–9PubMedCrossRef Cooper PJ, Fairburn CG. Cognitive behaviour therapy for anorexia nervosa: some preliminary findings. J Psychosom Res 1984; 28: 493–9PubMedCrossRef
22.
go back to reference Mitchell JE, Boutacoff LL, Hatsukami D, et al. Characteristics of 275 patients with bulimia. Am J Psychiatry 1985; 142: 462–85 Mitchell JE, Boutacoff LL, Hatsukami D, et al. Characteristics of 275 patients with bulimia. Am J Psychiatry 1985; 142: 462–85
23.
go back to reference Mitchell JE, Pomeroy C, Seppala M, et al. Diuretic use as a marker for eating problems and affective disorders among women. J Clin Psychiatry 1988; 49: 267–70PubMed Mitchell JE, Pomeroy C, Seppala M, et al. Diuretic use as a marker for eating problems and affective disorders among women. J Clin Psychiatry 1988; 49: 267–70PubMed
24.
go back to reference Steffen KJ, Mitchell JE, Roerig JL. The eating disorders medicine cabinet revisited: a clinician’s guide to ipecac and laxatives. Int J Eat Disord 2007; 40: 360–8PubMedCrossRef Steffen KJ, Mitchell JE, Roerig JL. The eating disorders medicine cabinet revisited: a clinician’s guide to ipecac and laxatives. Int J Eat Disord 2007; 40: 360–8PubMedCrossRef
25.
go back to reference Steffen KJ, Roerig JL, Mitchell JE, et al. A survey of herbal and alternative medication use among participants with eating disorder symptoms. Int J Eat Disord 2006; 39: 741–6PubMedCrossRef Steffen KJ, Roerig JL, Mitchell JE, et al. A survey of herbal and alternative medication use among participants with eating disorder symptoms. Int J Eat Disord 2006; 39: 741–6PubMedCrossRef
26.
go back to reference Wade TD. A retrospective comparison of purging type disorders: eating disorder not otherwise specified and bulimia nervosa. Int J Eat Disord 2007; 40: 1–6PubMedCrossRef Wade TD. A retrospective comparison of purging type disorders: eating disorder not otherwise specified and bulimia nervosa. Int J Eat Disord 2007; 40: 1–6PubMedCrossRef
27.
go back to reference Turner J, Batik M, Palmer LJ, et al. Detection and importance of laxative use in adolescents with anorexia nervosa. J Am Acad Child Adolesc Psychiatry 2000 Mar; 39(3): 378–85PubMedCrossRef Turner J, Batik M, Palmer LJ, et al. Detection and importance of laxative use in adolescents with anorexia nervosa. J Am Acad Child Adolesc Psychiatry 2000 Mar; 39(3): 378–85PubMedCrossRef
28.
go back to reference Bytzer P, Stokholm M, Andersen I, et al. Prevalence of surreptitious laxative abuse in patients with diarrhea of uncertain origin: a cost benefit analysis of a screening procedure. Gut 1989; 30: 1379–84PubMedPubMedCentralCrossRef Bytzer P, Stokholm M, Andersen I, et al. Prevalence of surreptitious laxative abuse in patients with diarrhea of uncertain origin: a cost benefit analysis of a screening procedure. Gut 1989; 30: 1379–84PubMedPubMedCentralCrossRef
29.
30.
go back to reference Harari D, Gurwitz JH, Avorn J, et al. Constipation: assessment and management in an institutionalized elderly population. J Am Geriatr Soc 1994; 42: 947–52PubMedCrossRef Harari D, Gurwitz JH, Avorn J, et al. Constipation: assessment and management in an institutionalized elderly population. J Am Geriatr Soc 1994; 42: 947–52PubMedCrossRef
31.
go back to reference Talley NJ. Definitions, epidemiology, and impact of chronic constipation. Rev Gastroenterol Disord 2004; 4 Suppl. 2: S3–10PubMed Talley NJ. Definitions, epidemiology, and impact of chronic constipation. Rev Gastroenterol Disord 2004; 4 Suppl. 2: S3–10PubMed
32.
go back to reference Primrose WR, Capewell AE, Simpson GK. Prescribing patterns observed in registered nursing homes and longstay geriatric wards. Age Ageing 1987; 16: 25–8PubMedCrossRef Primrose WR, Capewell AE, Simpson GK. Prescribing patterns observed in registered nursing homes and longstay geriatric wards. Age Ageing 1987; 16: 25–8PubMedCrossRef
33.
go back to reference Read NW, Krejs GJ, Read MG, et al. Chronic diarrhea of unknown origin. Gastroenterology 1980; 78: 264–71PubMed Read NW, Krejs GJ, Read MG, et al. Chronic diarrhea of unknown origin. Gastroenterology 1980; 78: 264–71PubMed
35.
go back to reference Greenfeld D, Mickley D, Quinlan DM, et al. Hypokalemia in outpatients with eating disorders. Am J Psychiatry 1995; 152: 60–3PubMedCrossRef Greenfeld D, Mickley D, Quinlan DM, et al. Hypokalemia in outpatients with eating disorders. Am J Psychiatry 1995; 152: 60–3PubMedCrossRef
36.
go back to reference Eherer AJ, Fordtran JS. Fecal osmotic gap and pH in experimental diarrhea of various causes. Gastroenterology 1992; 103: 545–51PubMedCrossRef Eherer AJ, Fordtran JS. Fecal osmotic gap and pH in experimental diarrhea of various causes. Gastroenterology 1992; 103: 545–51PubMedCrossRef
37.
go back to reference Phillips S, Donaldson L, Geisler K, et al. Stool composition in factitial diarrhea: a 6-year experience with stool analysis. Ann Intern Med 1995; 123: 97–100PubMedCrossRef Phillips S, Donaldson L, Geisler K, et al. Stool composition in factitial diarrhea: a 6-year experience with stool analysis. Ann Intern Med 1995; 123: 97–100PubMedCrossRef
39.
go back to reference Fine KD, Santa Ana CA, Fordtran JS. Diagnosis of magnesium-induced diarrhea. N Engl J Med 1991; 324: 1012–7PubMedCrossRef Fine KD, Santa Ana CA, Fordtran JS. Diagnosis of magnesium-induced diarrhea. N Engl J Med 1991; 324: 1012–7PubMedCrossRef
40.
go back to reference Mayo Foundation for Medical Education and Research. Mayo 2010 test catalog. Rochester (MN): Mayo Foundation for Medical Education and Research, 2010 Mayo Foundation for Medical Education and Research. Mayo 2010 test catalog. Rochester (MN): Mayo Foundation for Medical Education and Research, 2010
41.
go back to reference Kovacs D, Palmer RL. The associations between laxative abuse and other symptoms among adults with anorexia nervosa. Int J Eat Disord 2004; 36: 224–8PubMedCrossRef Kovacs D, Palmer RL. The associations between laxative abuse and other symptoms among adults with anorexia nervosa. Int J Eat Disord 2004; 36: 224–8PubMedCrossRef
42.
go back to reference Lacey JH, Gibson E. Does laxative abuse control body weight? A comparative study of purging and vomiting bulimics. Hum Nutr Appl Nutr 1985; 39: 36–42PubMed Lacey JH, Gibson E. Does laxative abuse control body weight? A comparative study of purging and vomiting bulimics. Hum Nutr Appl Nutr 1985; 39: 36–42PubMed
43.
go back to reference Bo-Linn GW, Santa Ana CA, Morawski SG, et al. Purging and calorie absorption in bulimic patients and normal women. Ann Intern Med 1983; 99: 14–7PubMedCrossRef Bo-Linn GW, Santa Ana CA, Morawski SG, et al. Purging and calorie absorption in bulimic patients and normal women. Ann Intern Med 1983; 99: 14–7PubMedCrossRef
44.
go back to reference Pryor T, Wiederman MW, McGilley B. Laxative abuse among women with eating disorders: an indication of psychopathology? Int J Eat Disord 1996; 20: 13–8PubMedCrossRef Pryor T, Wiederman MW, McGilley B. Laxative abuse among women with eating disorders: an indication of psychopathology? Int J Eat Disord 1996; 20: 13–8PubMedCrossRef
45.
go back to reference Rosenberg M. Society and the adolescent self-image. Princeton (NJ): Princeton University Press, 1965CrossRef Rosenberg M. Society and the adolescent self-image. Princeton (NJ): Princeton University Press, 1965CrossRef
46.
go back to reference Surgenor LJ, Maguire S, Russell J, et al. Self-liking and self-competence: relationship to symptoms of anorexia nervosa. Eur Eat Disord Rev 2007; 15: 139–45PubMedCrossRef Surgenor LJ, Maguire S, Russell J, et al. Self-liking and self-competence: relationship to symptoms of anorexia nervosa. Eur Eat Disord Rev 2007; 15: 139–45PubMedCrossRef
47.
go back to reference Bryant-Waugh R, Turner H, East P, et al. Misuse of laxatives among adult outpatients with eating disorders: prevalence and profiles. Int J Eat Disord 2006; 39: 404–9PubMedCrossRef Bryant-Waugh R, Turner H, East P, et al. Misuse of laxatives among adult outpatients with eating disorders: prevalence and profiles. Int J Eat Disord 2006; 39: 404–9PubMedCrossRef
48.
go back to reference Weltzin TE, Bulik CM, McConaha CW, et al. Laxative withdrawal and anxiety in bulimia nervosa. Int J Eat Disord 1995; 17: 141–6PubMedCrossRef Weltzin TE, Bulik CM, McConaha CW, et al. Laxative withdrawal and anxiety in bulimia nervosa. Int J Eat Disord 1995; 17: 141–6PubMedCrossRef
49.
go back to reference Wiederman MW, Pryor T. Multi-impulsivity among women with bulimia nervosa. Int J Eat Disord 1996; 20: 359–65PubMedCrossRef Wiederman MW, Pryor T. Multi-impulsivity among women with bulimia nervosa. Int J Eat Disord 1996; 20: 359–65PubMedCrossRef
50.
go back to reference Favaro A, Santonastaso P. Impulsive and compulsive self-injurious behavior in bulimia nervosa: prevalence and psychological correlates. J Nerv Ment Dis 1998; 186: 157–65PubMedCrossRef Favaro A, Santonastaso P. Impulsive and compulsive self-injurious behavior in bulimia nervosa: prevalence and psychological correlates. J Nerv Ment Dis 1998; 186: 157–65PubMedCrossRef
51.
go back to reference Mond JM, Hay PJ, Rodgers B, et al. Correlates of self-induced vomiting and laxative misuse in a community sample of women. J Nerv Ment Dis 2006; 194: 40–6PubMedCrossRef Mond JM, Hay PJ, Rodgers B, et al. Correlates of self-induced vomiting and laxative misuse in a community sample of women. J Nerv Ment Dis 2006; 194: 40–6PubMedCrossRef
52.
go back to reference Haedt AA, Edler C, Heatherton TF, et al. Importance of multiple purging methods in the classification of eating disorder subtypes. Int J Eat Disord 2006; 39: 648–54PubMedCrossRef Haedt AA, Edler C, Heatherton TF, et al. Importance of multiple purging methods in the classification of eating disorder subtypes. Int J Eat Disord 2006; 39: 648–54PubMedCrossRef
53.
go back to reference Hatsukami D, Eckert E, Mitchell JE, et al. Affective disorders and substance abuse in women with bulimia. Psychol Med 1984; 14: 701–4PubMedCrossRef Hatsukami D, Eckert E, Mitchell JE, et al. Affective disorders and substance abuse in women with bulimia. Psychol Med 1984; 14: 701–4PubMedCrossRef
54.
go back to reference Mitchell JE, Hatsukami D, Pyle RL, et al. Bulimia with and without a family history of depressive illness. Compr Psychiatry 1986; 27: 215–9PubMedCrossRef Mitchell JE, Hatsukami D, Pyle RL, et al. Bulimia with and without a family history of depressive illness. Compr Psychiatry 1986; 27: 215–9PubMedCrossRef
55.
go back to reference Cance JD, Ashley OS, Penne MA. Unhealthy weight control behaviors and MDMA ecstasy use among adolescent females. J Adolesc Health 2005; 37: 409PubMedCrossRef Cance JD, Ashley OS, Penne MA. Unhealthy weight control behaviors and MDMA ecstasy use among adolescent females. J Adolesc Health 2005; 37: 409PubMedCrossRef
56.
go back to reference Hatsukami D, Mitchell JE, Eckert ED, et al. Characteristics of patients with bulimia only, bulimia with affective disorders, and bulimia with substance abuse problems. Addict Behav 1986; 11: 399–406PubMedCrossRef Hatsukami D, Mitchell JE, Eckert ED, et al. Characteristics of patients with bulimia only, bulimia with affective disorders, and bulimia with substance abuse problems. Addict Behav 1986; 11: 399–406PubMedCrossRef
57.
go back to reference Jonas JM, Gold MS, Sweeney D, et al. Eating disorders and cocaine abuse: a survey of 259 cocaine abusers. J Clin Psychiatry 1987; 48: 47–50PubMed Jonas JM, Gold MS, Sweeney D, et al. Eating disorders and cocaine abuse: a survey of 259 cocaine abusers. J Clin Psychiatry 1987; 48: 47–50PubMed
58.
go back to reference Johnson CL, Love SQ. Bulimia: multivariate predictors of life impairment. J Psychiatr Res 1985; 19: 343–7PubMedCrossRef Johnson CL, Love SQ. Bulimia: multivariate predictors of life impairment. J Psychiatr Res 1985; 19: 343–7PubMedCrossRef
59.
go back to reference Latner JD, Vallance JK, Buckett G. Health-related quality of life in women with eating disorders: association with subjective and objective binge eating. J Clin Psychol Med Settings 2008; 15: 148–53PubMedCrossRef Latner JD, Vallance JK, Buckett G. Health-related quality of life in women with eating disorders: association with subjective and objective binge eating. J Clin Psychol Med Settings 2008; 15: 148–53PubMedCrossRef
60.
go back to reference Anderson CB, Carter FA, McIntosh VV, et al. Self-harm and suicide attempts in individuals with bulimia nervosa. Eat Disord 2002; 10: 227–43PubMedCrossRef Anderson CB, Carter FA, McIntosh VV, et al. Self-harm and suicide attempts in individuals with bulimia nervosa. Eat Disord 2002; 10: 227–43PubMedCrossRef
61.
go back to reference Duncan A, Forest JAH. Surreptitious abuse of magnesium laxatives as a cause of chronic diarrhea. Eur J Gastroenterol Hepatol 2001; 13: 599–601PubMedCrossRef Duncan A, Forest JAH. Surreptitious abuse of magnesium laxatives as a cause of chronic diarrhea. Eur J Gastroenterol Hepatol 2001; 13: 599–601PubMedCrossRef
63.
go back to reference Kreek MJ. Constipation syndromes. In: Lewis JH, editor. A pharmacological approach to gastrointestinal disorders. Baltimore (MD): Williams & Wilkins, 1994: 179–208 Kreek MJ. Constipation syndromes. In: Lewis JH, editor. A pharmacological approach to gastrointestinal disorders. Baltimore (MD): Williams & Wilkins, 1994: 179–208
64.
go back to reference Izzo AA, Gaginella TS, Mascolo N, et al. Recent findings on the mode of action of laxatives: the role of platelet activating factor and nitric oxide. Trends Pharmacol Sci 1998; 19: 403–5PubMedCrossRef Izzo AA, Gaginella TS, Mascolo N, et al. Recent findings on the mode of action of laxatives: the role of platelet activating factor and nitric oxide. Trends Pharmacol Sci 1998; 19: 403–5PubMedCrossRef
65.
go back to reference Willard SG, Winstead DK, Anding R, et al. Laxative detoxification in bulimia nervosa. In: Johnson WG, editor. Advances in eating disorders: bulimia nervosa: perspectives on clinical research and therapy. Greenwich (CT): JAI Press Inc., 1989 Willard SG, Winstead DK, Anding R, et al. Laxative detoxification in bulimia nervosa. In: Johnson WG, editor. Advances in eating disorders: bulimia nervosa: perspectives on clinical research and therapy. Greenwich (CT): JAI Press Inc., 1989
66.
go back to reference Coogan PF, Rosenberg L, Palmer JR, et al. Phenolphthalein laxatives and risk of cancer. J Natl Cancer Inst 2000; 23: 1943–4CrossRef Coogan PF, Rosenberg L, Palmer JR, et al. Phenolphthalein laxatives and risk of cancer. J Natl Cancer Inst 2000; 23: 1943–4CrossRef
67.
go back to reference Cooper GS, Longnecker MP, Peters RK. Ovarian cancer risk and use of phenolphthalein-containing laxatives. Pharmacoepidemiol Drug Saf 2004; 13: 35–9PubMedCrossRef Cooper GS, Longnecker MP, Peters RK. Ovarian cancer risk and use of phenolphthalein-containing laxatives. Pharmacoepidemiol Drug Saf 2004; 13: 35–9PubMedCrossRef
68.
go back to reference US Food and Drug Administration. Laxative drug products for over-the-counter human use; proposed amendment to the tentative final monograph. Fed Regist 1997 Sep 2; 62: 46223–7 US Food and Drug Administration. Laxative drug products for over-the-counter human use; proposed amendment to the tentative final monograph. Fed Regist 1997 Sep 2; 62: 46223–7
69.
go back to reference Dunnick JK, Hardisty JF, Herbert RA, et al. Phenolphthalein induces thymic lymphomas accompanied by loss of the p53 wild type allele in heterozygous p53-deficient +/-mice. Toxicol Pathol 1997; 25: 533–40PubMedCrossRef Dunnick JK, Hardisty JF, Herbert RA, et al. Phenolphthalein induces thymic lymphomas accompanied by loss of the p53 wild type allele in heterozygous p53-deficient +/-mice. Toxicol Pathol 1997; 25: 533–40PubMedCrossRef
72.
go back to reference Saunders DR, Sillery J, Rachmilewitz D, et al. Effect of bisacodyl on structure and function of rodent and human intestine. Gastroenterology 1977; 72: 849–56PubMed Saunders DR, Sillery J, Rachmilewitz D, et al. Effect of bisacodyl on structure and function of rodent and human intestine. Gastroenterology 1977; 72: 849–56PubMed
73.
go back to reference Sonnenberg A, Müller AD. Constipation and cathartics as risk factors of colorectal cancer: a meta-analysis. Pharmacology 1993; 47 Suppl. 1: 224–33PubMedCrossRef Sonnenberg A, Müller AD. Constipation and cathartics as risk factors of colorectal cancer: a meta-analysis. Pharmacology 1993; 47 Suppl. 1: 224–33PubMedCrossRef
74.
go back to reference Jacobs EJ, White E. Constipation, laxative use, and colon cancer among middle-aged adults. Epidemiology 1998; 9: 385–91PubMedCrossRef Jacobs EJ, White E. Constipation, laxative use, and colon cancer among middle-aged adults. Epidemiology 1998; 9: 385–91PubMedCrossRef
75.
go back to reference Nusko G, Schneider B, Ernst H, et al. Melanosis coli: a harmless pigmentation or a precancerous condition? Z Gastroenterol 1997; 35: 313–8PubMed Nusko G, Schneider B, Ernst H, et al. Melanosis coli: a harmless pigmentation or a precancerous condition? Z Gastroenterol 1997; 35: 313–8PubMed
76.
go back to reference Stoll RE, Blanchard KT, Stoltz JH, et al. Phenolphthalein and bisacodyl: assessment of genotoxic and carcinogenic responses in heterozygous p53 (+/-) mice and Syrian hamster embryo (SHE) assay. Toxicol Sci 2006; 90: 440–50PubMedCrossRef Stoll RE, Blanchard KT, Stoltz JH, et al. Phenolphthalein and bisacodyl: assessment of genotoxic and carcinogenic responses in heterozygous p53 (+/-) mice and Syrian hamster embryo (SHE) assay. Toxicol Sci 2006; 90: 440–50PubMedCrossRef
77.
go back to reference Nusko G, Schneider B, Schneider I, et al. Anthranoid laxative use is not a risk factor for colorectal neoplasia: results of a prospective case control study. Gut 2000; 46: 651–5PubMedPubMedCentralCrossRef Nusko G, Schneider B, Schneider I, et al. Anthranoid laxative use is not a risk factor for colorectal neoplasia: results of a prospective case control study. Gut 2000; 46: 651–5PubMedPubMedCentralCrossRef
78.
go back to reference Dukas L, Willett WC, Colditz GA, et al. Prospective study of bowel movement, laxative use, and risk of colorectal cancer among women. Am J Epidemiol 2000; 151: 958–64PubMedCrossRef Dukas L, Willett WC, Colditz GA, et al. Prospective study of bowel movement, laxative use, and risk of colorectal cancer among women. Am J Epidemiol 2000; 151: 958–64PubMedCrossRef
79.
go back to reference Kune GA, Kune S, Field B, et al. The role of chronic constipation, diarrhea, and laxative use in the etiology of large-bowel cancer: data from the Melbourne Colorectal Cancer Study. Dis Colon Rectum 1988; 31: 507–12PubMedCrossRef Kune GA, Kune S, Field B, et al. The role of chronic constipation, diarrhea, and laxative use in the etiology of large-bowel cancer: data from the Melbourne Colorectal Cancer Study. Dis Colon Rectum 1988; 31: 507–12PubMedCrossRef
80.
go back to reference Nascimbeni R, Donato F, Ghirardi M, et al. Constipation, anthranoid laxatives, melanosis coli, and colon cancer: a risk assessment using aberrant crypt foci. Cancer Epidemiol Biomarkers Prev 2002; 11: 753–7PubMed Nascimbeni R, Donato F, Ghirardi M, et al. Constipation, anthranoid laxatives, melanosis coli, and colon cancer: a risk assessment using aberrant crypt foci. Cancer Epidemiol Biomarkers Prev 2002; 11: 753–7PubMed
81.
go back to reference Roberts MC, Millikan RC, Galanko JA, et al. Constipation, laxative use, and colon cancer in a North Carolina population. Am J Gastroenterol 2003; 98: 857–64PubMedCrossRef Roberts MC, Millikan RC, Galanko JA, et al. Constipation, laxative use, and colon cancer in a North Carolina population. Am J Gastroenterol 2003; 98: 857–64PubMedCrossRef
82.
go back to reference Fioramonti J, Bueno L. Toxicity of laxatives: how to discriminate between myth and fact? Eur J Gastroenterol Hepatol 1995; 7: 5–7PubMed Fioramonti J, Bueno L. Toxicity of laxatives: how to discriminate between myth and fact? Eur J Gastroenterol Hepatol 1995; 7: 5–7PubMed
83.
go back to reference Muller-Lissner SA, Kamm MA, Scarpignato C, et al. Myths and misconceptions about chronic constipation. Am J Gastroenterol 2005; 100: 232–42PubMedCrossRef Muller-Lissner SA, Kamm MA, Scarpignato C, et al. Myths and misconceptions about chronic constipation. Am J Gastroenterol 2005; 100: 232–42PubMedCrossRef
84.
go back to reference Drug facts and comparisons 2006. 60th ed. Philadelphia (PA): Lippincott, Williams & Wilkins, 2006 Drug facts and comparisons 2006. 60th ed. Philadelphia (PA): Lippincott, Williams & Wilkins, 2006
85.
go back to reference Anderson JW, Zettwoch N, Feldman T, et al. Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hyper-cholesterolemic men. Arch Intern Med 1988; 148: 292–6PubMedCrossRef Anderson JW, Zettwoch N, Feldman T, et al. Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hyper-cholesterolemic men. Arch Intern Med 1988; 148: 292–6PubMedCrossRef
86.
go back to reference Bell LP, Hectorne K, Reynolds H, et al. Cholesterol-lowering effects of psyllium hydrophilic mucilloid: adjunct therapy to a prudent diet for patients with mild to moderate hypercholesterolemia. JAMA 1989; 261: 3419–23PubMedCrossRef Bell LP, Hectorne K, Reynolds H, et al. Cholesterol-lowering effects of psyllium hydrophilic mucilloid: adjunct therapy to a prudent diet for patients with mild to moderate hypercholesterolemia. JAMA 1989; 261: 3419–23PubMedCrossRef
87.
go back to reference Levin EG, Miller VT, Muesing RA, et al. Comparison of psyllium hydrophilic mucilloid and cellulose as adjuncts to a prudent diet in the treatment of mild to moderate hypercholesterolemia. Arch Intern Med 1990; 150: 1822–7PubMedCrossRef Levin EG, Miller VT, Muesing RA, et al. Comparison of psyllium hydrophilic mucilloid and cellulose as adjuncts to a prudent diet in the treatment of mild to moderate hypercholesterolemia. Arch Intern Med 1990; 150: 1822–7PubMedCrossRef
88.
go back to reference Als-Nielsen B, Gluud LL, Gluud C. Nonabsorbable disaccharides for hepatic encephalopathy. Cochrane Database Syst Rev 2004; 2: CD003044 Als-Nielsen B, Gluud LL, Gluud C. Nonabsorbable disaccharides for hepatic encephalopathy. Cochrane Database Syst Rev 2004; 2: CD003044
89.
go back to reference Loening-Baucke V, Pashankar DS. A randomized, prospective, comparison study of polyethylene glycol 3350 without electrolytes and milk of magnesia for children with constipation and fecal incontinence. Pediatrics 2006; 118: 528–35PubMedCrossRef Loening-Baucke V, Pashankar DS. A randomized, prospective, comparison study of polyethylene glycol 3350 without electrolytes and milk of magnesia for children with constipation and fecal incontinence. Pediatrics 2006; 118: 528–35PubMedCrossRef
90.
go back to reference Slugg PH, Carey WD. Clinical features and follow-up of surreptitious laxative users. Cleveland Clin Q 1984; 51: 167–71CrossRef Slugg PH, Carey WD. Clinical features and follow-up of surreptitious laxative users. Cleveland Clin Q 1984; 51: 167–71CrossRef
91.
go back to reference Krahn LE, Lee J, Richardson JW, et al. Hypokalemia leading to torsades de pointes: Munchausen’s disorder or bulimia nervosa? Gen Hosp Psychiatry 1997; 19: 370–7PubMedCrossRef Krahn LE, Lee J, Richardson JW, et al. Hypokalemia leading to torsades de pointes: Munchausen’s disorder or bulimia nervosa? Gen Hosp Psychiatry 1997; 19: 370–7PubMedCrossRef
92.
go back to reference Wright LF, DuVal Jr JW. Renal injury associated with laxative abuse. South Med J 1987; 80: 1304–6PubMedCrossRef Wright LF, DuVal Jr JW. Renal injury associated with laxative abuse. South Med J 1987; 80: 1304–6PubMedCrossRef
93.
go back to reference Vanderperren B, Rizzo M, Angenot L, et al. Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides. Ann Pharmacother 2005; 39: 1353–7. Epub 2005 Jun 14PubMedCrossRef Vanderperren B, Rizzo M, Angenot L, et al. Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides. Ann Pharmacother 2005; 39: 1353–7. Epub 2005 Jun 14PubMedCrossRef
94.
95.
go back to reference Corbi G, Acanfora D, Iannuzzi GL, et al. Hypermagnesemia predicts mortality in elderly with congestive heart disease: relationship with laxative and antacid use. Rejuvenation Res 2008; 11: 129–38PubMedCrossRef Corbi G, Acanfora D, Iannuzzi GL, et al. Hypermagnesemia predicts mortality in elderly with congestive heart disease: relationship with laxative and antacid use. Rejuvenation Res 2008; 11: 129–38PubMedCrossRef
96.
go back to reference Sebastian AN, Hulter HN, Rector BC. Metabolic alkalosis. In: Brenner BM, Stein JH, editor. Contemporary issues in nephrology, acid-base and potassium homeostasis. New York: Churchill-Livingstone, 1978: 101–36 Sebastian AN, Hulter HN, Rector BC. Metabolic alkalosis. In: Brenner BM, Stein JH, editor. Contemporary issues in nephrology, acid-base and potassium homeostasis. New York: Churchill-Livingstone, 1978: 101–36
97.
go back to reference Kobayashi N, Tamai H, Uehata S, et al. Pancreatic abnormalities in patients with eating disorders. Psychosom Med 1988; 50: 607–14PubMedCrossRef Kobayashi N, Tamai H, Uehata S, et al. Pancreatic abnormalities in patients with eating disorders. Psychosom Med 1988; 50: 607–14PubMedCrossRef
98.
go back to reference Brown NW, Treasure JL, Campbell IC. Evidence for long-term pancreatic damage caused by laxative abuse in subjects recovered from anorexia nervosa. Int J Eat Disord 2001; 29: 236–8PubMedCrossRef Brown NW, Treasure JL, Campbell IC. Evidence for long-term pancreatic damage caused by laxative abuse in subjects recovered from anorexia nervosa. Int J Eat Disord 2001; 29: 236–8PubMedCrossRef
100.
go back to reference Cummings JH, Sladen GE, James OF, et al. Laxative-induced diarrhoea: a continuing clinical problem. BMJ 1974; 23: 537–41CrossRef Cummings JH, Sladen GE, James OF, et al. Laxative-induced diarrhoea: a continuing clinical problem. BMJ 1974; 23: 537–41CrossRef
101.
go back to reference LaRusso NF, McGill DB. Surreptitious laxative ingestion. Delayed recognition of a serious condition: a case report. Mayo Clin Proc 1975; 50: 706–8PubMed LaRusso NF, McGill DB. Surreptitious laxative ingestion. Delayed recognition of a serious condition: a case report. Mayo Clin Proc 1975; 50: 706–8PubMed
102.
103.
104.
go back to reference Sansone RA. Complications of hazardous weight-loss methods. Am Fam Physician 1984; 30: 141–6PubMed Sansone RA. Complications of hazardous weight-loss methods. Am Fam Physician 1984; 30: 141–6PubMed
105.
go back to reference Cuellar RE, Van Thiel DH. Gastrointestinal consequences of the eating disorders: anorexia nervosa and bulimia. Am J Gastroenterol 1986; 81: 1113–24PubMed Cuellar RE, Van Thiel DH. Gastrointestinal consequences of the eating disorders: anorexia nervosa and bulimia. Am J Gastroenterol 1986; 81: 1113–24PubMed
106.
go back to reference Mitchell JE, Seim HC, Colon E, et al. Medical complications and medical management of bulimia. Ann Intern Med 1987; 107: 71–7PubMedCrossRef Mitchell JE, Seim HC, Colon E, et al. Medical complications and medical management of bulimia. Ann Intern Med 1987; 107: 71–7PubMedCrossRef
107.
go back to reference Weiss BD, Wood GA. Laxative abuse causing gastrointestinal bleeding. J Fam Pract 1982; 15: 177–81PubMed Weiss BD, Wood GA. Laxative abuse causing gastrointestinal bleeding. J Fam Pract 1982; 15: 177–81PubMed
108.
go back to reference Mitchell JE, Pyle RL, Eckert ED, et al. Electrolyte and other physiological abnormalities in patients with bulimia. Psychol Med 1983; 13: 273–8PubMedCrossRef Mitchell JE, Pyle RL, Eckert ED, et al. Electrolyte and other physiological abnormalities in patients with bulimia. Psychol Med 1983; 13: 273–8PubMedCrossRef
109.
go back to reference Wald A. Is chronic use of stimulant laxatives harmful to the colon? J Clin Gastroenterol 2003; 36: 386–9PubMedCrossRef Wald A. Is chronic use of stimulant laxatives harmful to the colon? J Clin Gastroenterol 2003; 36: 386–9PubMedCrossRef
110.
go back to reference Morales MA, Hernández D, Bustamante S, et al. Is senna laxative use associated to cathartic colon, genotoxicity, or carcinogenicity? J Toxicol 2009; 2009: 287247PubMedPubMedCentralCrossRef Morales MA, Hernández D, Bustamante S, et al. Is senna laxative use associated to cathartic colon, genotoxicity, or carcinogenicity? J Toxicol 2009; 2009: 287247PubMedPubMedCentralCrossRef
111.
112.
go back to reference Wu WJ, Huang CH, Chiang CP, et al. Urolithiasis related to laxative abuse. J Formos Med Assoc 1993; 92: 1004–6PubMed Wu WJ, Huang CH, Chiang CP, et al. Urolithiasis related to laxative abuse. J Formos Med Assoc 1993; 92: 1004–6PubMed
113.
go back to reference Malik M, Stratton J, Sweeney WB. Rectal prolapse associated with bulimia nervosa: report of seven cases. Dis Colon Rectum 1997; 40: 1382–5PubMedCrossRef Malik M, Stratton J, Sweeney WB. Rectal prolapse associated with bulimia nervosa: report of seven cases. Dis Colon Rectum 1997; 40: 1382–5PubMedCrossRef
114.
go back to reference Mitty RD, Wolfe GRZ, Cosman M. Initial description of gastric melanosis in a laxative-abusing patient. Am J Gastroenterol 1997; 92: 707–8PubMed Mitty RD, Wolfe GRZ, Cosman M. Initial description of gastric melanosis in a laxative-abusing patient. Am J Gastroenterol 1997; 92: 707–8PubMed
116.
go back to reference Lin CC, Chan TY, Deng JF. Clinical features and management of herb-induced aconitine poisoning. Ann Emerg Med 2004; 43: 574–9PubMedCrossRef Lin CC, Chan TY, Deng JF. Clinical features and management of herb-induced aconitine poisoning. Ann Emerg Med 2004; 43: 574–9PubMedCrossRef
118.
go back to reference Harper J, Leung M, Birmingham CL. A blinded laxative taper for patients with eating disorders. Eat Weight Disord 2004; 9: 147–50PubMedCrossRef Harper J, Leung M, Birmingham CL. A blinded laxative taper for patients with eating disorders. Eat Weight Disord 2004; 9: 147–50PubMedCrossRef
119.
go back to reference Colton P, Woodside DB, Kaplan AS. Laxative withdrawal in eating disorders: treatment protocol and 3 to 20-month follow-up. Int J Eat Disord 1999; 25: 311–7PubMedCrossRef Colton P, Woodside DB, Kaplan AS. Laxative withdrawal in eating disorders: treatment protocol and 3 to 20-month follow-up. Int J Eat Disord 1999; 25: 311–7PubMedCrossRef
120.
go back to reference Cooper PJ, Fairburn CG. The eating disorders examination: a semi-structured interview for the assessment of the specific psychopathology of the eating disorders. Int J Eat Disord 1987; 6: 1–8CrossRef Cooper PJ, Fairburn CG. The eating disorders examination: a semi-structured interview for the assessment of the specific psychopathology of the eating disorders. Int J Eat Disord 1987; 6: 1–8CrossRef
Metadata
Title
Laxative Abuse
Epidemiology, Diagnosis and Management
Authors
James L. Roerig
Kristine J. Steffen
Professor James E. Mitchell
Christie Zunker
Publication date
01-08-2010
Publisher
Springer International Publishing
Published in
Drugs / Issue 12/2010
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.2165/11898640-000000000-00000

Other articles of this Issue 12/2010

Drugs 12/2010 Go to the issue

Adis Drug Profile

Oral Bepotastine

Adis Drug Evaluation

Glatiramer Acetate